Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2026-06-13 @ 10:09 PM
Study NCT ID:
NCT00700206
Status:
COMPLETED
Last Update Posted:
2011-10-12
First Post:
2008-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study Comparing Two Dose Schedules of Telintra™ in Myelodysplastic Syndrome (MDS)
Sponsor:
Telik
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TLK199.2101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None